Is Abbott Stock A Buy As Worries Of A Second Coronavirus Wave Spread?Investors Business Daily • 06/15/20
2 Million Patients And Beyond: Abbott’s FreeStyle Libre 2 Cleared In The U.S. For Adults And Children With DiabetesForbes • 06/15/20
Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance StandardsPRNewsWire • 06/15/20
New Late-Breaking Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1C Levels in People with Type 2 Diabetes Using Insulin or NotPRNewsWire • 06/13/20
Abbott Releases Interim Clinical Study Data on ID NOW COVID-19 Rapid Test Showing Strong Agreement to Lab-Based Molecular PCR TestsPRNewsWire • 05/21/20